Vamotinib
Catalog No.
BA8806
Vamotinib (PF-114) is a potent, selective tyrosine kinase inhibitor with oral activity.
Featured Products
Vamotinib (PF-114) is a potent, selective tyrosine kinase inhibitor with oral activity.Vamotinib inhibits autophosphorylation of BCR/ABL and BCR/ABL-T315I.Vamotinib induces apoptosis.Vamotinib shows antiproliferative and antitumor activity.Vamotinib has potential in the drug-resistant Philadelphia chromosome-positive (Ph+) leukemia.Vamotinib inhibited the ABL family of kinases by 0.49nM (ABL), 0.78nM (ABL), 9.5nM (ABL), 2.0nM (ABL), 7.4nM (ABL), 1.0nM (ABL), 2.8nM (ABL), respectively. 12nM (ABL) and 4.1nM (ABL).
| Physical Appearance | A solid |
| Storage | 4°C, desiccated and protect from light |
| M.Wt | 532.56 |
| Cas No. | 1416241-23-0 |
| Formula | C29H27F3N6O |
| Synonyms | PF-114 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |







